SV Health Investors’s Misonix Inc MSON Stock Holding History

SV Health Investors’s Portfolio MSON Stock Details MSON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,694,017	Closed	-$42.9M	–	9
2021 Q3	$42.9M	Hold	1,694,017	–	–	20.97%	3
2021 Q2	$37.6M	Hold	1,694,017	–	–	16.37%	3
2021 Q1	$33.2M	Hold	1,694,017	–	–	12.43%	4
2020 Q4	$21.2M	Sell	1,694,017 -1,952	-0.1%	-$24.6K	10.2%	6
2020 Q3	$19.9M	Hold	1,695,969	–	–	10.08%	5
2020 Q2	$23M	Hold	1,695,969	–	–	15.96%	3
2020 Q1	$16M	Hold	1,695,969	–	–	13.4%	5
2019 Q4	$31.6M	Hold	1,695,969	–	–	19.12%	1
2019 Q3	$34.1M	Buy	+1,695,969	New	+$36.7M	23.94%	1

Other funds holding MSON

Cambridge Trust Cambridge, Massachusetts $2.64B AUM 28.73% 1-Year Est. Return

SV Health Investors's MSON Position: Q4 2021 in Review

SV Health Investors sold out of Misonix Inc (MSON) in Q4 2021, closing a stake of 1,694,017 shares — an estimated $42.9M sold.

SV Health Investors first reported a position in MSON in Q3 2019 and held it in 9 quarters. The position peaked at $42.9M in Q3 2021. 1 fund tracked by Wall St. Rank holds MSON as of Q4 2021.

SV Health Investors reported no remaining Misonix Inc position as of Q4 2021 after selling out during the quarter.
SV Health Investors sold 1,694,017 Misonix Inc shares in Q4 2021, an estimated $42.9M.
SV Health Investors first reported a position in Misonix Inc in Q3 2019 and held it in 9 quarters.
SV Health Investors's Misonix Inc position peaked at $42.9M in Q3 2021.
1 fund tracked by Wall St. Rank held Misonix Inc as of Q4 2021.

Based on SV Health Investors's 13F filing for Q4 2021, filed 11 Feb 2022.